Dr. Melillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2554 Bear Den Rd
Frederick, MD 21701Phone+1 301-639-2190
Education & Training
- University of Naples Faculty of MedicineClass of 1981
Certifications & Licensure
- MD State Medical License 2000 - 2025
Clinical Trials
- UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma Start of enrollment: 2002 Jun 01
Publications & Presentations
PubMed
- 5 citationsAssociation of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation.Sophie Wildsmith, Jiabu Ye, April Franks, Giovanni Melillo, Jon Armstrong
Cancer Research Communications. 2022-01-01 - 11 citationsCurative-Intent Treatment with Durvalumab in Early-Stage Cancers.Giovanni Melillo, Vikram Chand, Alejandro Javier Yovine, Ashok K. Gupta, Cristian Massacesi
Advances in Therapy. 2021-04-21 - 5 citationsSUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of ...Sara I. Pai, Ezra E.W. Cohen, Derrick T. Lin, George Fountzilas, Edward S. Kim
Journal of Translational Medicine. 2019-12-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: